Zvinoenderana nemhedzisiro yakaziviswa pamusangano wepagore we2018 ASCO, iyo CDK4/6 inhibitors pabociclib (Ibrance) uye cetuximab (Erbitux) yakasanganiswa kurapwa kweplatinamu-inodzivirira uye HPV-yakasununguka inodzokororwa / metastatic musoro uye ne.